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ABSTRACT 
This project involved an assessment of research carried out at an off-campus site 
that addressed a problem related to adipose differentiation   PRMTs are a class 
of histone modifers, which can help “open” or “close” DNA by methylating 
histone tails at arginine residues.  PRMTs are especially important during 
differentiation, when turning genes “on” and “off” is crucial.  Recent findings 
show that PRMT4 & PRMT5 are required for muscle differentiation.  The project’s 
purpose was to determine if PRMT4 & PRMT5 are also required for adipose 
differentiation.  This was accomplished by comparing the efficiency of 
differentiation of a fibroblast into an adipocyte, using wild-type, PRMT4-, and 
PRMT5- fibroblast cell lines.  Fibroblasts are capable of transdifferentiating into 
adipocytes after being given a nuclear hormone receptor, PPAR-gamma, and 
the ligand, troglitazone.  mRNA expression results show adipose genes (Leptin,  
Resistin, and FAS) are transcribed at significantly lower rates in cells lacking 
PRMT5.  Expression of adipose mRNAs was significantly higher in wild-type cells: 
159,900% for resistin, 3,256% for FAS, and 1,750% higher for leptin.  Lipid stains 
show that cells lacking PRMT5 did not produce nearly as much lipid as wild-type 
cells.  These results suggest that PRMT5 is required for adipose differentiation. The 
PRMT4 experiment never produced a complete and reproducible set of mRNA 
expression data or consistent lipid stains.  In the PRMT4 experiment, Resistin 
mRNA was found to be expressed 2,264% more in PRMT4- cells.  And, AP2 mRNA 
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expression was found to be 57% higher in PRMT4+ cells.  This incomplete and 
conflicting data might have been due to difficulty with bacterial contamination 
and inefficient MEF 13 retroviral infections.  Modifications to the protocol could 
provide the opportunity retrieve reproducible data from the PRMT4 experiment.  
And, adding protein data to both the PRMT4 and PRMT5 experiments would 
make the results more complete.  Knowing the role of PRMT4 and PRMT5 in 
adipose differentiation would help clarify the role PRMTs (histone modifiers) play 
in the differentiation process.
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INTRODUCTION 
 
Chromatin & Histones 
 
Almost two meters of DNA is compacted to fit into the eukaryotic nucleus 
through the use of proteins, especially histones.  The complex of proteins and 
DNA is called chromatin.  The histone packaging proteins (H1, H2A, H2B, H3, and 
H4) are small, positively charged (basic) proteins that can bind to negatively 
charged DNA.  Histones contain many basic amino acids.  These include lysine 
and arginine.  In some histones, the percentage of lysine is as high as 27% of the 
amino acids, and the percentage of arginine can be as high as 15% (See Figure 
1).    No histone has more than 265 amino acids.  H1, also known as linker histone, 
is the largest of all the histones. 
Figure 1 shows data on histones including amino acid size and % arginine. (Waterborg, 1998) 
Histone Amino Acids % Arginine 
H1 200-265 2 
H2A 129-165 9 
H2B 121-148 6 
H3 135 15 
H4 102 4 
 
There are 4 core histones and 1 linker histone.  Core histones (H2A, H2B, H3, and 
H4) have the same basic structure.  Core histones contain a long hydrophobic 
alpha helix surrounded by two shorter hydrophobic alpha helices.  These 
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structures enable core histones to interact such that an octamer can form.  
Histone subunit H2A interacts with H2B, and H3 interacts with H4.  To form the 
histone core octamer, three steps must occur.  First an H3-H4 tetramer must form.  
Then, two H2A-H2B dimers must form.  Then, these 3 subunits must combine to 
form an octamer.  (Peterson, 2004) 
   
Nucleosomes consist of DNA wound around a group of eight histones, called an 
octamer.  Two of H2A, H2B, H3, and H4 subunits make up the octamer, while a 
single H1 subunit exists outside the octamer.  145 base pairs of DNA wrap around 
the histone octamer approximately 1 and ¾ turns.  Between 10 and 60 base 
pairs exist between nucleosomes as “linker” DNA.  “Linker” DNA can easily 
associate with proteins while DNA wound around the histone octamer cannot.  
In this way, chromatin structure can regulate gene transcription. 
 
Two forms of chromatin can be isolated from cells.  At low ion concentration, 
chromatin is isolated in a form known as “beads on a string” (10nm thick).  This 
form of chromatin contains single nucleosomes separated by “linker” DNA.  H1 is 
usually absent with this form of chromatin. Gene transcription commonly occurs 
in this form of chromatin.  At physiological ion concentration, chromatin is 
isolated in a 30nm fiber form that is much denser than the “beads on a string” 
form.  This form exists as a solenoid of nucleosomes.  This type of chromatin is not 
genetically transcribed.  Also, this form contains a much higher level of H1 linker 
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histone than the 10nm form.  (Of note: Histone H1 stabilizes interactions between 
nucleosomes).  Denser conformations of chromatin can exist during mitosis, 
especially metaphase.  Conformations of chromatin can reach 100-400nm thick.  
However, the 300nm looped domain conformation is best documented.  This 
consists of loops of 30nm chromatin fibers looped and attached to a protein 
scaffold.  300nm chromatin forms chromosomes, which are 700nm in width or 
1400nm during mitosis.  
 
Chromatin remodeling enzymes have the ability to alter the structure of 
chromatin so that proteins can bind to certain regions and are blocked from 
binding to others.  One class of chromatin remodeling enzymes is the histone 
modifiers (See Figure 2).  These enzymes can add a variety of functional groups 
to histones.  And, the functional groups are most frequently added to the tails of 
the histones.  Histone tails are 20-35 amino acid residues long on the amino 
terminal.  These extensions from the nucleosome contain amino acids that are 
basic (positively charged).  Histone tails function to bind to DNA, fold chromatin, 
and to interact with other histones.   
 
Another common type of chromatin remodeling enzyme is related to 2MDa 
yeast SWI/SNF complex.  These enzymes use energy, ATP, to break histone-DNA 
bonds (Salma, 2004).  Another common type of chromatin remodeling enzyme 
is a class of nuclear histone acetyltransferases (HATs).  These enzymes modify 
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histones by adding acetyl groups to lysines in the histone proteins.  HATs belong 
to the histone modifers, but because they have been studied for so long, many 
scientists consider them to be their own category of chromatin remodeling 
enzymes. 
 
SWI/SNF complexes (in vitro) have been shown to remodel chromatin.  In vitro 
results show (1) greater accessibility of DNA to protein factors, (2) loss of coiling in 
the chromatin, and (3) shifting of position of histone octamers.  Researchers 
believe that ATP is used to “drive a change in the twist of nucleosomal DNA” to 
remodel the chromatin (de la Serna, 2006).  Two SWI/SNF-like complexes are 
found in mammalian cells and are known as hSWI/SNF or BAF.  These enzymes 
have an ATPase subunit, which is either BRG1 or BRM.   These enzymes are 
needed to make activators function.  Some of these activators include the 
estrogen receptor, heat shock factor, and glucocorticoid receptor.  SWI/SNF 
enzymes mostly activate genes.   
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Figure 2 shows different mechanisms that regulate genes: transcription factors and chromatin 
remodeling enzymes.  The project focused on histone methylation enzymes. 
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Post-translational modifications to histone tails are very common.  Acetylation, 
methylation, phosphorylation, ubiquitylation, sumoylation, and ribosylation are 
some of the common modifications.  However, histone acetylation is the best 
known.  Acetylation involves the reversible addition of acetyl groups to N-
terminal core histones.  Acetylation is associated with (1) reduced binding of 
histones to DNA and (2) less stable forms of chromatin.   Acetylation occurs on 
lysines, which are highly conserved in H3 and H4 histones.  Histone Acetyl 
Transferases (HAT) enzymes and histone deacetylase enzymes control these 
reactions.   
 
Each post-translational modification also has a level of complexity.  For example, 
there is more than one way to methylate an arginine.  In fact PRMTs can modify 
arginines in at least four different ways.  In addition, multiple arginines can be 
modified.  And modifications can occur at different histones.  Recent studies 
suggest that histone modifications can even occur deep within the histone core, 
not just on histone tails. 
 
 
 
PRMTs (Protein Arginine Methyl Transferases) & Arginine 
 
There are 20 standard amino acids.  However, posttranslational modifications to 
amino acids can extend this number.  Post-translational modifications are useful 
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for changing protein structures, which can activate or turn off that protein’s 
function.  Methylation is a common post-translational modification.  According 
to one study published in 2003, it is estimated that 1% of all mammalian genes 
encode methyltransferase enzymes (Fackelmayer, 2005).  PRMTs are a type of 
enzyme that methylates arginine amino acids (See Figure 3) in both cytoplasmic 
and nuclear proteins, using the conserved methyltransferase (MTase) domain.  
PRMTs are expressed ubiquitously in human cells but can have specificity based 
on alternative splicing.  PRMT1 and PRMT4 are vital for existence.   
 
PRMTs are classified based on how they methylate arginine residues.  Arginine 
consists of an “R-group” (CH2)3-NH-CNH2NH2.  Because arginine contains 3 
nitrogen groups, methylation can occur at 3 different sites (see Figure 3 below).   
PRMTs transfer methyl groups from S-adenosylmethionine (AdoMet) to nitrogen 
groups on arginine.  The top nitrogen circled in red in figure 3 is known as the 
delta nitrogen.  The other two nitrogens on the end of the arginine are known as 
omega nitrogens.  At most, the delta nitrogen can receive one methyl group 
(see Figure 4 below).  The omega nitrogens could each receive two methyl 
groups.  If arginine receives one methyl group it is known as mono-methylated 
arginine (MMA). If arginine receives two methyl groups it is known as di-
methylated arginine (DMA).  Di-methylated arginines can be asymmetrical, 
which means they have methyl groups added to the same omega nitrogen 
(notated as aDMA).  However, di-methylated arginines can also be symmetrical, 
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which means they have methyl groups on both omega nitrogens (notated as 
sDMA).  
 
Figure 3  The figure on the left shows arginine, and the figure on the right shows the sites where 
potential methylation can occur.  A positive charge is distributed over the two outermost 
nitrogen groups.   
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Figure 4 shows the possible methylation products of the four classes of PRMTs.  A positive charge 
is distributed over the two outermost nitrogen groups.   
 
 
PRMTs are classified as either Type 1, 2, 3, or 4.  Type 1, 2, and 3 methylate 
omega nitrogens.  Type 1 form asymmetrical di-methylated arginines (aDMA).  
Type 2 form symmetrical di-methylated arginines (sDMA).  Both Type 1 and Type 
2 PRMTs form di-methylated arginines from mono-methylated arginine 
intermediates.  Type 3 enzymes form a variety of mono-methylated arginines 
(MMA).  Type 4 PRMTs only methylate the internal or delta nitrogen.   
PRMT 4 = Type 1 = Asymmetric Di-Methylation 
PRMT 5 = Type 2 = Symmetric Di-Methylation 
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PRMT# Classification 
Type 
PRMT1 1 
PRMT2 4 
PRMT3 1 
PRMT4 1 
PRMT5 2 
PRMT6 1 
PRMT7 2,3 
PRMT8 1 
PRMT9 2 
Figure 5 shows classifications of PRMTs and definitions of each classification. 
 
Several types of methyltransferases exist and are categorized by class.  Class 1 
has a seven-stranded Beta-sheet structure.  Class 2 are SET lysine 
methyltransferases.  A third class exists and is involved with membrane-bound 
methylation.  PRMTs belong to Class 1 methyltransferases.  As of December 2007, 
10 mammalian PRMTs have been identified.  However, PRMT2 and PRMT9 have 
not demonstrated methylation activity (Bedford, 2008).   
 
PRMTs contain 5 “signature” motifs.  These include VLD/EVGxGxG, V/IxG/AxD/E, 
F/VVDI/L/K and LR/KxxG and a THW loop.  Each PRMT contains these 5 motifs 
(see Figure 6).  PRMT2 also carries a SH3 domain and PRMT3 contains a Zn++ 
Classification 
Type 
Description 
1 (aDMA) = asymmetrical     
di-methylated arginine 
2 (sDMA)= symmetrical di-
methylated arginine 
3 (MMA) = mono methylated 
arginine 
4 (omega MMA) = mono 
methylated arginine  
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finger domain which aid in recognition of the substrate.  PRMT7 also contains a 
duplication of the 5 motifs.  PRMT4 contains one of each of these motifs in the 
center of the protein.  PRMT5 also contains each of these motfis.  However, 
these motifs are found on the ends of the protein.  Each of these motifs in PRMT4 
and PRMT5 both have good sequence similarity to PRMT consensus motif 
sequences. 
 
Figure 6 shows the 5 conserved motifs of PRMTS. This image was obtained from Arginine Methylation an 
Emerging Regulator of Protein Function by Mark T. Bedford and Stephane Richard. (Bedord, 2005) 
 
 
Proteins with methylated arginines are involved with (1) DNA repair, (2) RNA 
metabolism, and (3) transcriptional regulation.   PRMTs mostly methylate within 
GAR motifs (Glycine and Arginine), which are found on the substrate.  Arginine 
methylation can be carried out in multiple ways.    Methylated arginines have a 
variety of functions including regulation of transcription, nuclear trafficking, 
mRNA splicing, and DNA repair.   PRMTs are expressed in all cells and may have 
a “housekeeping” function.  Experimental evidence shows that PRMT-deficient 
mouse embryos die at or before birth (Yadav, 2003).  However, stem cells from 
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the embryo are viable and do not have noticeable defects.  These results 
suggest that PRMTs are needed for differentiation.   
 
When arginine is methylated, the net “+” charge does not change.  As a result, 
the properties of arginine should remain fairly similar to arginine that is not 
methylated.  It is believed that methylated arginine does not act like an on/off 
switch, but either slightly dims or increases its activity.  Experiments have shown 
that cells without PRMTs usually still have some level of activity associated with 
methylated arginines.   
 
Until recently, arginine methylation was thought to be a permanent or very long 
lived modification.  However, in 2004 demethylases were discovered.  One of 
first of these proteins discovered was peptidyl arginine deiminase (PAD-4).  In 
2007, an arginine demethylase was discovered and named JMJD6.  It contains 
a Jumonji domain.  In total, two families of arginine demethylases have been 
discovered.  Still, the difference in prevalence of PRMTs and demethylases is 
substantial.  Some PRMTs are seen as “housekeeping” proteins found in all cells.  
Arginine demethylases have only been found in a few cell types with Ca2+ 
concentrations high enough for activation.  Most cells do not have arginine 
demethylases.   
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PRMT4 and PRMT5 = 
Chromatin Remodeling Enzymes
Chromatin Remodeling Enzymes
•Transcription regulation
•DNA repair
•Cell cycle regulation
Protein Arginine Methyltransferases
(PRMTs)
• Methylate histone protein tails on 
arginine residues
• Can activate or repress transcription
 
Figure 7 shows a summary of information about PRMT chromatin remodeling enzymes. 
 
 PRMT4 (CARM1) 
PRMT4 (608 amino acids) is also known as CARM1, Coactivator-associated 
arginine methyltransferase, has been shown to increase transcription (Wyatt, 
2007).  PRMT4 is a secondary coactivator.  It is recruited to the promoter site of 
hormone response genes via glucocorticoid receptor-interacting protein-1 
(GRIP1, SRC2/TIF2).  Once there PRMT4 interacts with histone acetyltransferase 
p300/CBP and AIB1, while methylating Arg17 and Arg26 on histone 3, resulting in 
gene activation.  CARM 1 is also able to methylate p300/CBP, RNA-binding 
proteins, and splicing factors.  NUMAC is a protein discovered to regulate PRMT4.  
Kinases phosphorylation is associated with decreased activity of PRMT4.  Of note, 
PRMT4 overexpression is associated with breast and prostate tumors.       
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It should be noted that p300/CBP modifies histones by adding acetyl groups to 
lysine amino acids.  It is believed that there is “interplay” between lysine 
acetylation and arginine methylation.  This is not the only example of 
cooperative histone modification.      
Proteins Methylated 
by PRMT4 
Substrate 
Function 
 
Histone H3 
Histone H2A 
CBP 
P300 
A1B1 
Chromatin-
Associated 
SmB 
CA150 
U1C 
SAP49 
hnRNPs and 
splicing 
PABP1 
HuR 
HuD 
mRNA-binding  
FTARPP Signalling 
Figure 8 shows a list of proteins methylated by PRMT4. 
 
 PRMT5 
Less is known about PRMT5 (637 amino acids) compared to PRMT4.  PRMT5 
modifies arginines on H2A, H3, and H4 histone subunits and can be found in both 
the cytoplasm and nucleus.  Cytoplasmic PRMT5 is involved with the 
methylsome, which methylates Sm proteins.  Nuclear PRMT5 is involved with SPT4 
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and SPT5 transcription regulators.  Nuclear PRMT5 also complexes with human 
SWI/SNF ATPase proteins BRG and BRM, which increases PRMT activity.   Recent 
findings suggest higher PRMT5 methylation levels of H3R8 in lymphoid cancer 
(Pal, 2007).  Experiments show that this methylation can result in either increased 
or decreased transcription.  PRMT5 is believed to operate with chromatin 
remodeling complexes (hSWI/SNF, BRG1/BRM, and MBD2-based NURD).  These 
chromatin remodeling complexes enable PRMT5 to reach histone tails where it 
can modify arginine amino acids.  
Proteins Methylated 
by PRMT5 
Substrate 
Function 
 
Histone H4 
Histone H3 
Histone H2A 
SPT5 
FCP1 
Chromatin-
Associated 
SmB 
CA150 
SmD1 and D3 
hnRNPs and 
splicing 
EBNA1 
EBNA2 
Viral Proteins 
Figure 9 shows a list of proteins methylated by PRMT5. 
 
 
More about PRMT Substrates 
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While Glycine and Arginine (GAR) motifs are common methylation sites for 
PRMTs, Proline, Glycine, Methionine, and Arginine (PGM) motifs are also 
common sites for methylation.  As an exception, PRMT4 cannot methylate GAR 
motifs.  As a result, it mostly methylates PGM motifs.  PRMT5 methylates both GAR 
and PGM motifs.  PRMT4 and PRMT5 are the only two PRMTs that can methylate 
PGM motifs.   
 
 
Adipose Differentiation Pathway & Peroxisome Proliferator-Activated Receptor 
Gamma (PPAR Gamma) 
 
Peroxisome Proliferator –Activated Receptors (PPARs) exhibit 3 isoforms - alpha, 
delta, and gamma (Mukherjee, 2002).  These molecules increase production of 
peroxisomes, organelles involved in fatty acid metabolism.  Peroxisomes mainly 
work through beta-oxidation, the breakdown of fatty acids into Acetyl-CoA 
molecules (Tontonoz, 1994). 
 
PPARs are part of the Nuclear Receptor (NR) family.  Nuclear Receptors are 
proteins activated by hormones that regulate gene expression.   NRs have 5 
domains: N-terminal, DNA-binding (DBD), hinge, Ligand-binding (LBD), and C-
terminal domains.  The hinge domain connects the DBD to the LBD (Salma, 2006). 
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PPARs function as Type II NRs.  Type II receptors bind to corepressors when the 
ligand is absent.  After biding the ligand, they dissociate from the corepressor 
and hetero-dimer with RxR (retinoid X receptor).  (See Figure 10)  Then, they 
recruit coregulatory proteins and RNA polymerase to regulate gene transcription.  
These regulatory proteins can be involved in chromatin remodeling or 
recruitment of other proteins to DNA.  Two common coactivator proteins 
associated by PPAR-gamma are Src-1 and Tif2 (Marathe, 2007).   
 
The general mechanism of action for PPAR is to bind a ligand, dimerize with 
retinoid x receptor (RXR), and bind Peroxisome Proliferator Response Elements 
(PPREs) with coregulators.  The PPRE is found in the promoter and has the 
consensus sequence AGGTCAXAGGTCA.  Genes are then either activated or 
repressed.  It is important to note that PPARs regulate gene expression related to 
lipid metabolism.  Because of this, PPARs are clinically important because it is 
associated with diseases such as obesity, cancer, atherosclerosis, and diabetes.   
 
The ligands for PPARs are either fatty acid derivatives or derived from 
Thiazolidinedione. Derivates of Thiazolidinedione include Troglitazone (Rezulin), 
Piogliazone (Actos), and Rosiglitazone (Avandia).  Troglitazone was used as the 
ligand for this experiment.  
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Adipose differentiation begins when fatty acids or fatty acid derivatives bind to 
the PPAR-gamma receptor (See Figure 5).   The receptor then binds to RXR 
(Retinoid x Receptor) and forms a heterodimer.  The complex then binds to DNA 
and binds to other transcription factors.  This leads to gene activation and 
adipose differentiation as well as an increase in insulin sensitivity. 
 
Of note, drugs called thiazolidinediones (TZDs) treat type II Diabetes by binding 
to PPAR-gamma receptors.  Activation of the PPAR-gamma receptor leads to 
an increase in insulin sensitivity.  TZDs are sold under names such as Avandia, 
Actos, and Rezulin.  An unwanted side effect of these drugs is an increase in 
weight! 
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Figure 10 shows the adipose differentiation pathway. 
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Adipose mRNA Markers 
• Leptin – This 16-kDa hormone (167 amino acid protein) is produced by 
adipocytes.  The amount of leptin in the blood stream is directly 
proportional to the amount of body fat.  It binds to LepR(x) receptors, 
where x is a, b, c, d, e, or f.  Leptin binds to several regions of the brain, 
including the hypothalamic nuclei and hypothalamus.  Binding of leptin to 
its receptor tells the brain to produce a signal of fullness or satiety.   
• Resistin – Resistin is a protein hormone found in mice that acts on the liver.  
It is 108 amino acids in length and causes insulin resistance effects in the 
liver.  Because the liver stores sugar deposits as glycogen, it plays an 
important role in regulating blood sugar.  Insulin resistance of the liver 
causes blood sugar levels to increase.  This is because insulin tells the body 
to reduce blood sugar levels.  Of note, macrophages in mice also 
produce large amounts of resistin.  
• Fatty Acid Synthase – FAS (272kDa) is responsible for converting 
carbohydrates to fat.  It is the only enzyme with the ability to create fat, 
however fat can still be obtained through diet.  Inhibitors of FAS have 
been developed by several companies to help fight obesity.  Recently, 
however, FAS has been implicated in tumor growth.  And, FAS inhibitors 
have been found to help prevent tumors.   
• AP2 – Adipocyte Protein 2 is also known as Fatty Acid Binding Protein 4 
(FABP4).  FABP4 is a cytoplasmic protein that attaches to hydrophobic 
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substrates, such as fatty acids.  Proteins in the class of FABP are involved 
with fatty acid metabolism and transport.   
 
 
Recent Research Findings 
 
PRMT4 
Recent research into PRMT4 has revealed a link between the enzyme and 
activation of estrogen-mediated genes.  It is believed that this activation is 
caused by methylation of H3 and H4 histones.  It is also believed that PRMT4 acts 
at “estrogen-induced promoters” as part of a chromatin remodeling complex.  
PRMT4 has also been shown to be involved in myogenesis. 
 
PRMT5 
Recent finding about PRMT5 have revealed that it may be involved with 
repression of “growth control” and tumor suppression.  Also, PRMT5 has been 
shown to decrease elongation factor Spt5’s affinity for RNA polymerase – thus 
repressing gene expression. Generally, PRMT5 is able to repress genes by 
methylating histones and transcriptional subunits.   
 
Dr. Imbalzano’s Lab Findings 
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In 2007, my research mentor Caroline Dacwag published an article in the journal 
Molecular and Cellular Biology showing evidence that suggests PRMT5 is 
needed for myogenesis (muscle cell differentiation).   
 
Muscle cell differentiation requires several transcription factors, including MyoD, 
Myf5, Mrf4, myogenin, and Mef2 members.  These transcription factors are 
needed for gene activation during differentiation.  The role of chromatin 
remodeling enzymes in myogenic gene activation had not been thoroughly 
studied.  As a result, my mentor Caroline Dacwag set out to determine the role 
of PRMT5 in muscle differentiation. 
 
Prior to her experiments, research on chromatin remodeling enzymes and 
myogenic gene expression revealed both positive and negative myogenic 
gene expression effects.  At the time, a recent study linked PRMT4 to myogenesis 
(Chen, 2001).  Because PRMT5 is a close relative of PRMT4 and because PRMT5 
and PRMT4 had both been linked to another chromatin remodeling subunit, 
BRG1 (ATPase subunit of SWI/SNF), the role of PRMT5 in myogenesis was explored.  
 
Dacwag used 3T3 fibroblasts to determine the role of PRMT5 in myogenesis.  
Dacwag used the knowledge that 3T3 fibroblasts expressing MyoD initiate 
myogenesis differentiation (Dacwag, 2007). Dacwag also used fibroblasts 
deficient in PRMT5 from an antisense vector.  Fibroblasts deficient in PRMT5 did 
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not activate myogenic genes.  Dacwag was able to show that the lack of 
arginine methylation on Histone 3 resulted in a loss of interaction with SWI/SNF 
subunit Brg1 and no ATP driven chromatin remodeling.  Of note, PRMT5 was also 
shown to interact with transcription factor myogenin’s promoter.  (Myogenin is 
one of the earliest genes activated in the muscle cell differentiation pathway.) 
 
 
Because the lab had previously sponsored adipose research and still had 
adipose cells culturing, the logical question was to ask if either PRMT4 or PRMT5 is 
needed for adipose differentiation. This MQP utilized the results of experiments 
performed during the past summer as the basis for this final report. 
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Hypothesis 
 
It is predicted that because PRMT4 and PRMT5 are needed for muscle 
differentiation, they should also be required for adipose differentiation.  It is 
expected that PRMT4- and PRMT5- cell lines should not transdifferentiate into 
adipose as efficiently as wild-type fibroblasts.  As a result, there should be fewer 
lipids, fewer adipose mRNAs (leptin, fatty acid synthase, resistin, AP2), and fewer 
adipose proteins in PRMT4- and PRMT5- cells, compared to wild-type cells. 
 
 
Figure 11 shows the experimental objective.  It is known that fibroblasts can be 
transdifferentiatied into adipocytes when given PPAR-gamma.  It is unknown if either PRMT4 or 
PRMT5 chromatin remodeling enzymes is needed during this process.  If adipose differentiation is 
not as efficient when either PRMT4 or PRMT5 is removed, then adipose differentiation requires 
these chromatin remodeling enzymes. 
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MATERIALS/METHODS 
 
 
Figure 12 shows a brief experimental summary.  
 
Cell Culture Materials 
• Incubator (capable of operating at 37oC) 
• 60 and 100mm Cell Culture Plates 
• 95% Ethanol Spray  
• Pasteur Pipets  
• 1, 5, 10, 25 mL Pipets 
• 15 and 50 mL conical tubes 
• PBS (Phosphate Buffered Saline) 
• Trypsin (10X stock diluted 1:10 with 1XPBS) 
• DMEM (Dulbecco’s modified Eagle’s medium) 
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• 10% Calf Serum/ 10% Fetal Calf Serum 
• Puromycin (diluted 1:1000 from stock to 2ug/mL) 
• Glutamine (essential for cell culture but added separately to media 
because of stability issues)  
• Penicillin-Streptomycin (bacterial antibiotics) - Penicillin blocks cell wall 
formation in Gram- bacteria, while streptomycin blocks protein synthesis in 
Gram+ bacteria.   
• Normocin Antibiotic (stock = 50mg/mL, used at 5mg/mL) - Normocin is 
commonly used, alone or with Pen/Strep, to prevent growth of 
mycoplasma (bacteria without cell walls), fungus, and bacteria.  
Normocin is bactericidal, killing bacteria, not just preventing their growth.  
Normocin prevents Gram+ and Gram- bacterial growth.  One active 
ingredient binds to the 50s ribosome subunit, blocking protein synthesis.  
The other component interferes with DNA synthesis.  Mammalian cells are 
not affected by Normocin.  Of note, Normocin also blocks flungal growth 
by interfering with ion exchange.  A third component of Normocin acts on 
yeast and fungus but not bacteria. 
• IBMX (.5mM), Insulin (.5ug/mL), and Dexamethasone (.5ug/mL) – 
IsoButylMethylXanthine is used in combination with insulin and 
dexamethasone for differentiation into adipocytes.  IBMX activates CEBP-
alpha, CEBP-beta, CEBP-delta, and PPARy transcription factors.  This results 
in adipose differentiation.   
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• Polybrene (1ug/mL) is added to media to help viral infection.  Polybrene is 
a positive molecule that binds to the surface of the cell and neutralizes 
the charge so that viral glycoprotiens can bind to receptors more 
efficiently.   
• Troglitazone is a member of the thiazolidinediones and is the ligand for 
PPAR-gamma.   
• TRIzol Reagent – This chemical (from Invitrogen) was used to isolate RNA.  
TRIzol disrupts cells and dissolves cellular components without damaging 
RNA.    
• Inverted Light Microscope and Digital Camera 
Cell Lines 
• Mouse Embryonic Fibroblast Cells (MEF 13, 20, 20.3) -– Three MEF cell lines 
were cultured.  MEF 13 cells were wild-type.  MEF 20 cells (PRMT4-) were 
made with “transfection of Carm1-/- lines with PCAGGS-FLPe-puro”.  Of 
note, these cells were donated by Dr.Mark Bedford.  He obtained these 
cells via S. Dymecki of Harvard Medical School.  MEF 20.3 cells were 
created via PRMT4- cells that had PRMT4 function restored.  This was done 
using a Flp/puro construct.  MEF 20.3 are essentially wild-type cells.  (The 
MEF cells required a 10% DMEM and Calf Serum mixture and were difficult 
to split.) 
• 3T3 and C15 Fibroblast Cells – Two 3T3 derived cell lines were cultured.  
The wild-type cells are called 3T3.  The PRMT5- cells were made from 3T3, 
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but are called C15 (Clone 15).  PRMT5- cells were made by using an anti-
sense PRMT5 vector, which reduced both protein and mRNA expression.  
These cells are also known as NIH 3T3/AS-PRMT5 (AS = Antisense).  (3T3-
derived cells required a 10% DMEM and Calf Serum mixture.) 
• BOSC Packaging Cell Lines (BOSC-alpha, BOSC-beta, BOSC-gamma 
viruses) -– The BOSC cells produce a retrovirus that carries a gene needed 
for adipose differentiation (PPAR-gamma).  Three BOSC cell lines were 
cultured during the experiment BOSC-CEBP-alpha, BOSC-CEBP-beta, and 
BOSC-PPAR-gamma.  However, only BOSC-PPAR-gamma was used to 
infect cells.  Each BOSC produces a retrovirus that carries a master 
adipose differentiation gene.  The gene encodes a receptor that can 
bind a ligand, troglitazone.  When the ligand troglitazone binds to the 
receptor, it activates adipose genes and induces differentiation.  Each 
BOSC line carries a gene that acts as a master adipose differentiator.  
(These cells required 10% DMEM and Fetal Calf Serum mixture and were 
easy to split.) 
 
It should be noted that retroviruses are enveloped viruses and contain 
RNA.  Once inside the host cell, the RNA is converted to DNA using reverse 
transcriptase.  Then, the enzyme integrase is used to integrate the viral 
DNA into the host DNA.   
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• NOTE: [The BOSC cell line, C15 cells, and 20.3 cells have innate Puromycin 
(PURO) resistance.  Puromycin is an antibiotic that kills both prokaryotes 
and eukaryotes by blocking translation of mRNA.  Puromycin looks like an 
aminoacylated tRNA.  So, it attaches to the growing polypeptide chain, 
but then causes the chain to release before completion of translation.]     
 
Lipid Stain Materials 
• Oil O Red 
• Isopropanol 
• ddH2O 
• Buffered Formalde Fresh (10% Formalin) – (Formalin is another name for 
Formaldehyde.  It is commonly used to preserve tissues.) 
 
 Making Media 
500 mL DMEM (Gibco #11965-092) 
5 mL L-Glutamine (200 milimolar) 
5 mL Pen/Strep 
50 Calf Serum or Fetal Calf Serum 
Normocin Antibiotic (stock = 50mg/mL, used at 5mg/mL) 
Puromycin (diluted 1:1000) 
 
Step #1 Thawing Cells from N2 (l) Freezer (MEFs, 3T3s, BOSCs) 
  
 - 36 - 
1. Add 9mL of appropriate media into 15mL conical tube.  Do this for each 
vial of frozen cells that will be retrieved 
2. Remove vial from freezer  
3. Thaw vial in 37o C warm water bath 
4. Douse vial with 95% ethanol spray and dry 
5. Remove 1mL of vial contents and add to conical containing 9mL of 
media 
6. Centrifuge at 1.0-1.2 x 10^3 rpm for 2.5 minutes to pellet cells 
7. Aspirate media  
8. Resuspend pellet in 10mL of fresh media 
9. Add to plate 
10. Shake plate to distribute cells 
11.  Incubate at 37oC 
 
Step #2 Splitting/Passaging Cells on 10cm Plate 
 
1.  Spray hood with 95% and wipe away with paper towel 
2.  Aspirate media from plates using Pasteur pipets 
3.  Add enough PBS to cover cells (5-6 mLs).  Do not pipet directly on cells.  
Instead, pipet on side of plate. 
4.  Aspirate PBS using clean Pastuer pipet 
5.  Add .5-1mL of Trypsin and tilt plate to spread all around 
  
 - 37 - 
6.  Wait 3 minutes while cells detach.  7.  Hit the side of the plate against the 
table to help cells detach from plate.  
7.  Use microscope to verify detachment.  Cells should appear rounded when 
they have detached.  
8.  Add desired amount of media +10% serum to cells and resuspend.  (Serum 
inactivates the trypsin.) 
9.  Distribute the resuspended cells to new plates which already contain media, 
and split to a desired ratio.  (Add cells to media to ensure the cells attach to all 
surfaces of the plate surface.)  It is important to note that the total volume on a 
10cm plate is 10mLs.  The total volume on a 6cm plate is 5mLs.  These volumes 
can be used to calculate how much media + serum to add to the cell 
suspension.   
10. Evenly distribute cells by rotating and shaking plate back and forth.  (All cell 
plates can be shaken at once if they are placed on a cell tray.) 
11.  Incubate at 37oC on a flat cell tray.  If the tray is not flat, cells may not cover 
the surface evenly. 
 
Step #3  Retroviral Infection (Gamma Virus and Mock Virus) 
(Jain, 2007) 
 
Gamma Virus Media  
15 mL PPAR-gamma Virus 
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1 mL Calf Serum 
5 mL 10% CS + DMEM 
21 uL polybrene                     
 add 7mL/plate (enough for 3 plates) 
 
Mock Virus Media 
9 mL PBabe Virus 
1 mL Calf Serum 
11 mL 10% CS + DMEM 
21 uL polybrene 
 add 7mL/plate (enough for 3 plates) 
 
1. Cells should be between 50-60% confluent.  This is to ensure that the cells are 
in the cell cycle dividing and will incorporate the viral DNA. 
2. When cells reach 50% confluence, aspirate old media and add 7mLs viral 
media to plates. 
3. Incubate at 37oC for two days 
4. After two days, check confluency.  If cells are 100% confluent,change media 
to back to original media, but add puromycin to all media.  This will select for 
cells infected with virus.  The virus gave the cells puromycin resistance.  
Adding PURO will kill cells without resistance.  (Puromycin selects for cells that 
incorporated the virus) 
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5. After 2 days, check the confluency. 
6. When the confluence reaches 100%, add media containing ligand.  It is 
optional whether puromycin is added to the media beyond this step. 
 
Troglitazone Ligand Media  
10 mL of 10% FCS media 
1 uM Dexamethosone 
5ug/mL insulin 
10uM Troglitazone 
2ug/mL Puromycin 
 
7. After 2 days, change media to insulin media. 
 
Insulin Media 
10 mL 10% FCS media 
5 ug/mL insulin 
 
8. The insulin media keeps the cell growing.  Tests can be done at anytime after 
the insulin media has been added.  This media should be changed every two 
days.   
 
Step #4 Oil O Red Lipid Staining Test 
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1.  Add .50 grams of Oil O Red to 100 mLs of isopropanol and mix for 3 
hours 
2.  Add 40 mLs of ddH20 to 60mLs of the Oil O Red solution and incubate at 
RT for 1 hour 
3.  Filter stain through vacuum suction filter (.2 micron) 
4.  Aspirate cell media and wash with 1X PBS. 
5.  Add Buffered Formalde Fresh (10% formalin, Fisher Catalog # SF93-4)  to 
cover cells 
6.  Incubate at room temperature for half an hour 
7.  Aspirate and add Oil O Red to cover cells 
8.  Leave for 1 hour at room temperature 
9.  Dump Oil O Red off cells and wash with PBS 2-3 times.  Leave cells in PBS.   
10. Take images under microscope.   
 
 
Step #5 mRNA Testing 
  
mRNA isolation 
1. Lyse cells by adding 1mL TRIzol Reagent.  Add 1mL/10cm^2 plate. 
2. Incubate for 5 minutes at room temperature. 
3. Add .2mL chloroform per 1mL of TRIzol.  Scrape cells into eppendorf 
tube.  Cap tube and shake for 15 seconds.  
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4. Centrifuge at 12000x g for 15 minutes at 2oC. 
5. Transfer the upper aqueous phase to a fresh tube.  Add .5mL of 
isopropyl alcohol per 1mL of TRIzol reagent. 
6. Incubate for 10 minutes at room temperature. 
7. Centrifuge at 12000x g for 10 minutes at 2oC. 
8. Dry RNA pellet under vacuum centrifugation. 
9. Redissolve RNA in 100% formamide and store at -70oC 
 
TRIzol disrupts cellular components without harming RNA.  Adding chloroform 
and then centrifuging will cause the formation of two layers, one aqueous and 
one organic.  RNA stays in the aqueous phase.  The isopropyl alcohol acts to 
precipitate the RNA.   
 
 
Making cDNA from mRNA 
1. Resuspend 1ug RNA into DEPC water for a total volume of 10.5uL 
2. Place on ice for 5 minutes 
3. Add 19.5 uL of RT mix 
 
RT Mix (enough for 1 sample) 
10uL (1:100) 200ng random hexamer 
5x Buffer 
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1uL .1M DTT 
1.5uL 10mM dNTPs 
1uL MoMulV Reverese Transciptase 
 
4. Run PCR 
 
 
Composition of Media when Passaging Cells 
BOSC-PPAR-gamma 
 
C15 and MEF 20.3 MEF 13 and 20 and 
3T3 
10% DMEM 10% DMEM 10% DMEM 
Fetal Calf Serum Calf Serum Calf Serum 
Penicillin-
Streptomycin (Pen-
Strep) 
Penicillin-
Streptomycin (Pen-
Strep) 
Penicillin-Streptomycin 
(Pen-Strep) 
Normocin Antibiotic Normocin Antibiotic Normocin Antibiotic 
 
PUROMYCIN PUROMYCIN No PUROMYCIN 
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Figure 13 shows the cell lines used in the experiment. 
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Figure 14 shows how the adipose differentiation pathway was built in a fibroblast.  The gene for 
the PPARy receptor was transferred to the fibroblast using a viral vector.  The ligand for the 
recptor was then added to the growth media given to the fibroblasts.  
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In order to transdifferentiate a fibroblast into an adipocyte, the fibroblast must 
be given the master adipose differentiator.  A virus can be used to introduce the 
genetic sequence for the receptor, PPAR-gamma.  In the experiment, MEF and 
3T3 cells were given either of two viruses.  One virus contained the PPAR-gamma 
gene and a puromycin resistance selection marker.  A second virus containing 
just a puromycin resistance selection marker was used as a control.  After 
infection, the virus-infected cells were selected for by adding puromycin to the 
growth media.  Cells not infected with the virus died.  After the cells became 
confluent, the ligand for the adipose receptor, IBMX , was added to the growth 
media.  Insulin was used as a growth signal to keep the cells growing.  After the 
cell plates became confluent tests for adipose differentiation were run.    
  
 - 46 - 
 
RESULTS 
8 weeks of Bacterial 
Contamination!!!
 
Figure 15 shows a tribute to the 8 weeks of bacterial contamination that plagued the project on 
and off. 
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Figure 16 shows the raw PPAR-gamma mRNA expression in the PRMT5 experiment.  The PRMT5 
mRNA data were adjusted such that the level of PPAR-gamma expression in the cells was equal.   
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Resistin mRNA Expression (PRMT5 Exp.)
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Figure 17 shows the Resistin mRNA expression for the PRMT5 experiment.  
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Figure 18 shows the AP2 mRNA expression for the PRMT5 experiment 
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FAS mRNA Expression (PRMT5 Exp.)
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Figure 19 shows FAS mRNA expression for the PRMT5 experiment 
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Leptin mRNA Expression (PRMT5 Exp)
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Figure 20 shows Leptin mRNA expression for the PRMT5 experiment 
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Figure 21 shows a summary of the mRNA expression results in the PRMT5- experiment. 
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Figure 22 shows the Oil O Red (lipid stain) for the PRMT5 experiment.  Lipid stains RED.  3T3 cells 
represent wild-type fibroblasts and C15 represent PRMT5 deficient cells.   
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Figure 23 shows mRNA expression of PPAR-gamma for the PRMT4 experiment.  The data were 
adjusted such that the relative expression of PPAR-gamma in the 20.3 and 20 were equal.   
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Figure 24 shows mRNA expression of Resistin in the PRMT4 experiment.   
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Figure 25 shows mRNA expression of AP2 in the PRMT4 experiment. 
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DISCUSSION 
 
Obstacles affecting data collection 
Contamination in the MEF cell lines set the project back several weeks.  
Randomly, during the course of the experiments, free-floating bacteria would 
appear in the cell cultures (See Figure 15).  The media in the cell culture disks 
would appear cloudy, with particulate matter floating in the media. The 
incubation time before the appearance of the bacteria could last as long as 2 
weeks.   The penicillin/streptomycin that was added to the media did not kill the 
bacteria.  Although Pen/Strep has the ability to kill both Gram+ and Gram- 
bacteria, resistance to these chemicals is becoming more common.  Eventually, 
Normocin antibiotic was added to the media to block growth.  The MEF data 
could only be obtained through the use of Normocin antibiotic. 
 
Inefficient PPAR-gamma and MOCK virus infections of the MEF13 cells left few 
cells alive after puromycin selection.  Without successful viral infection of the 
cells, no puromycin resistance could be obtained by the cells.  Therefore, when 
virus-infected cells were selected for by adding puromycin, most cells died.  
Waiting for the few cells left occupying the plate to become confluent slowed 
the experiment down.  In most cases, the MEFT13 cells were never able to grow 
to high enough confluence levels for tests to be performed.  In other words, 
there were not enough cells on the plate to run tests of mRNA, lipid, and protein. 
  
 - 53 - 
 
Innate puromycin-resistance in the MEF 20.3 and C15 cell lines prevented 
selection for virus-infected cells.  Because of this, cells not infected with virus 
continued through the experiment.  If the data were not normalized to account 
for PPAR-gamma expression, this would affect the results.  If the data were not 
normalized, the degree of lipid formation and adipose mRNA transcription 
would be reduced by the cells not infected, and therefore not differentiating.   
Normalizing PPAR-gamma expression ensures that the total production of PPAR-
gamma is the same on the wild-type plate and the experimental plate.  This is 
necessary because this method helps to “exclude” the cells not infected with 
PPAR-gamma and not producing adipose mRNAs.   
 
mRNA expression levels of Leptin and FAS were not reproduced in the PRMT4 
experiment.  The first trial revealed (1) mRNA expression of Leptin as 324.3% 
higher in Wild-Type cells compared to PRMT4- cells and (2) expression of FAS as 
48.9% higher in Wild-Type cells compared to PRMT4- cells.  However, during the 
second trial, this information was not successfully collected.  And, a mistake 
caused resisitin and FAS mRNA levels to not be taken.  Contamination was 
found in the second trial and data on mRNA expression was not collected.  As a 
result of the lack of reproducibility, this information was not included in the results 
section in proper graph format.  
 
  
 - 54 - 
The 10-week experimental time frame prevented additional experiments to 
tweak the protocol for a more complete set of data.  Several plans were made 
to alter the protocols to achieve better results, however, research mentors 
insisted on continuing with the established protocols.  Specifically, protein data 
was not collected in either experiment.  And, mRNA data was either not 
reproduced or not completely collected in the PRMT4 experiment. 
 
 Normalized mRNA Expression Data 
The data sets were normalized such that PPAR-gamma mRNA expression was 
the same in 3T3 and C15 cells (See Figure 16) and the same for MEF 20 and MEF 
20.3 cells (See Figure 23).  The reasons for differences in PPAR-gamma mRNA 
expression come from (1) different efficiencies of viral infection and (2) different 
efficiencies of gene transcription.  The location of viral gene incorporation (into 
the genome) can affect relative transcription into mRNA.  However, these 
discrepancies were eliminated when the data was normalized. 
 
PRMT5 mRNA Expression  
The adjusted mRNA data for the PRMT5 experiment shows that wild-type (3T3 
cells) produce more adipose mRNAs than PRMT5 knock-downs (C15 cells).  
Resistin mRNA production was 159,900% greater in 3T3 cells compared with C15 
cells (See Figure 17).  FAS mRNA production was 3,256% greater (See Figure 19), 
1,750% greater for leptin (See Figure 20) mRNA expression, and 2.559% greater 
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for AP2 expression (See Figure 18).  This data suggests that adipose 
differentiation is more efficient when PRMT5 is present.   
 
3T3 (WT) Cells Produce More Adipose mRNA than C15 (PRMT5-) Cells. 
Adipose mRNA % increased expression in Wild-Type 3T3 
cells 
Compared to PRMT5- Deficient Cells 
Resistin 159,900% 
FAS 3256% 
Leptin 1750% 
AP2 2.559% 
Figure 26 shows the adjusted mRNA data for the PRMT4 experiment.  
 
 
 
The adjusted mRNA data for the PRMT4 experiment shows that the cells with 
restored PRMT4 function (MEF 20.3) produce 57.20% more AP2 than PRMT4- cells 
(See Figure 25).  However, PRMT4- cells produced 2,264% more resistin mRNA 
than wild-type cells (See Figure 24). As noted earlier, Leptin and FAS data were 
omitted because they were never reproduced.  Leptin expression was 324.3% 
higher in wild-type cells.  FAS expression was 48.9% higher in PRMT4- cells.   
 
This set of data brings to light one concern. The problem is that two pieces of 
data are not valid because they were not reproduced.  When the data from 
the two valid trials is examined, it reveals that resistin mRNA expression is much 
higher in PRMT4- cells compared to wild-type cells.  This suggests that PRMT4 is 
not needed for adipose differentiation.  However, AP2 expression was higher in 
wild-type cells compared to PRMT4- cells.  This means that when PRMT4 function 
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was removed, AP2 expression decreased.  This suggests PRMT4 is needed for AP2 
expression.  No conclusion about whether PRMT4 is needed for adipose 
differentiation can be made.   
 
 
 
 
Adipose mRNA Transcription does NOT seem to depend on PRMT4. 
Adipose mRNA mRNA Expression (written in relative 
terms) 
Resistin 2,364% higher in MEF 20 
AP2 57.20% higher in MEF 20.3 
Figure 27 shows the adjusted mRNA data for the PRMT4 experiment. 
 
 
Oil O Red (Lipid Stain) 
 
The Oil O Red lipid stain clearly shows less lipid staining red in the C15 PRMT5- 
PPAR-gamma+ cells compared to the 3T3 wild-type cells infected with PPAR-
gamma (See Figure 22).  In other words, cells without PRMT5 produce fewer lipids 
than cells with PRMT5.  This suggests that PRMT5 is somehow needed for adipose 
differentiation.  Neither of the mock (control) infections produced anything 
more than background lipid staining.  The PRMT4 experiment did not have lipid 
data because neither the MEF13 nor MEF20 designated for lipid staining survived 
the infection.  The mock-infections (controls) do not show lipid staining because 
these cells were not given the master adipose differentiator PPAR-gamma.   
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CONCLUSIONS 
 
Results suggest that PRMT5 is needed for Adipose Differentiation 
Three of the four adipose mRNA markers tested (Resistin, FAS, Leptin) show at 
least 1750% increased mRNA expression in wild-type cells compared to cells 
deficient in PRMT5.  Leptin mRNA expression was 1750% higher in wild-type cells.  
Fatty acid synthase (FAS) mRNA expression was 3256% higher in wild-type cells.  
And, Resistin mRNA expression was 159,900% higher in wild-type cells.  This 
suggests that when cells become deficient in PRMT5, adipose mRNA production 
dramatically decreases.  From this, support is provided for the idea that PRMT5 is 
needed to enable these adipose genes to be expressed.   
 
It should be noted that AP2 expression was only slightly higher (2.55%) in wild-
type cells, compared to cells deficient in PRMT5.  This means that there is 
approximately the same level of AP2 mRNA expression in wild-type and PRMT5- 
cell lines.  However, this does not mean that PRMT5 is not involved in adipose 
differentiation.  It was assumed that AP2 would have a higher level of mRNA 
expression in adipose cells compared non-adipose cells.  However, this was 
never shown in the project.  The relative levels of AP2 mRNA expression in fully 
differentiated adipose and non-adipose cells should have been determined 
before the experiment as a control.  This way, it could be verified that AP2 (and 
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Resistin, FAS, and Leptin) mRNA expression is truly higher in adipose cells 
compared to non-adipose cells. 
 
(mRNA expression of adipose markers in adipocytes and fibroblasts could also 
be useful in measuring the extent of adipose differentiation.  In other words, 
adipose mRNA markers should have been measured in (1) fibroblasts and (2) 
adipocytes.  Then, a scale could be created for each adipose mRNA marker.  
Then, when fibroblasts are transdifferentiated into adipocytes, the mRNA 
expression levels could be used to determine the extent of adipocyte 
differentiation.)  
  
There is another possible reason why the AP2 mRNA expression was 
approximately equal in both wild-type and PRMT5- cell lines.  If the mRNA test 
had been done before the differentiation process was fully complete, the level 
of wild-type expression of AP2 might have increased as the differentiation 
process proceeded.  To address the issue of how far the differentiation process 
had proceeded, lipid and mRNA tests should have been done at different time 
intervals during the differentiation process.  This way, it could be ensured that 
the adipose cells were fully differentiated when the mRNA levels were 
determined.   
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There is still another possible explanation for why the AP2 mRNA expression was 
approximately equal in both wild-type and PRMT5- cell lines.  PRMT5 may not be 
involved in allowing this gene to be accessible for expression.  PRMT5 could still 
be involved in “opening” up many adipose genes for expression, but not AP2.  
Maybe, a different PRMT is involved in allowing PRMT5 to become accessible to 
protein factors.  Or, maybe experimental error caused a skewed result.  More 
tests confirming the AP2 data in the PRMT5 experiment would help clarify this 
topic.  And, collecting this data at different time intervals after differentiation 
would ensure that these mRNA levels are from fully differentiated adipose cells. 
 
From the Oil O Red lipid stain, it can be shown that only wild-type cells infected 
with the master adipose differentiator PPAR-gamma can produce lipid.  The Oil 
O Red stain reveals a strong presence of red-stained lipid in the environment, 
with localized red dots.  Red color was only lightly found in the background of 
the images of cells not infected with PPAR-gamma.  This is evidence that the cell 
plate was stained with a red dye.  However, the lack of a strong red color in the 
background and the lack of red color localized within the cells is evidence that 
the cells did not produce substantial amounts of lipids.  However, it is important 
to consider that all cells do produce lipids for (1) membranes, (2) energy storage, 
and (3) signaling.  These lipids are responsible for retaining a small amount of Oil 
Red O dye. 
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Cells deficient in PRMT5 did not produce lipid anywhere near the extent that 
wild-type cells did.  Only a faint dot of red is found in the image of cells infected 
with PPAR-gamma, but deficient in PRMT5.  This visual observation provides 
support for the idea that more lipid forms when PRMT5 is present.  And, this result 
was visually supported by viewing individual cells under a microscope at high 
magnification.  Wild-type cells infected with PPAR-gamma were found to 
contain several large granules, which resembled lipid granules.  An expert in the 
field of adipose tissue confirmed this observation.  These granules were not 
found in PRMT5- cells or any cells not infected with PPAR-gamma.   
 
This combination of Oil O Red lipid stain images, mRNA data, and the 
observation of numerous large granules in wild-type cells containing PPAR-
gamma supports the hypothesis that PRMT5 is involved in adipose differentiation.  
PRMT5- cells have fewer adipose mRNAs being expressed, less lipid staining red, 
and few if any granules resembling lipid droplets within the cells.  This supports 
the expected results of the hypothesis. This outcome that PRMT5 seems to be 
needed for adipose differentiation follows nicely in the footsteps of my research 
mentor’s recent finding that PRMT5 is needed for muscle cell differentiation.   
 
 
Results from PRMT4 Experiment are too incomplete to make Correlation 
  
 - 61 - 
The PRMT4 experiment did not produce any valid Oil O Red stains.  This was due 
to the fact that the MEF 13 (Wild-Type) cells infected with PPAR-gamma could 
not be produced in significant quantity to stain.  This was a caused by inefficient 
MEF13 viral infections.  Without viral infection and delivery of puromycin 
resistance to the MEF13 cells, they were killed when puromycin was added 
during the viral selection phase.  Without a wild-type to compare the PRMT4- 
cells to, staining the MEF20s was useless and therefore not done.  (Suggestions 
for improving the efficiency of the MEF 13 viral infection can be found later in 
this section.)   
 
The mRNA results for the PRMT4 experiment were also incomplete.  Although two 
pieces of data were retrieved, these pieces of information conflicted with each 
other.  Resistin expression was found to be over 2,264% higher in PRMT4- cells 
compared to cells with partially restored PRMT4 function.  And, AP2 expression 
was found to be 57.203% higher in cells with partially restored PRMT4 function 
(MEF 20.3) compared to PRMT4- cells.  It should be restated that MEF20.3 cells 
are not wild-type but are rescued versions of PRMT4- deficient cells (MEF20s).  In 
this way, MEF20.3 cells can act like a wild-type, with active PRMT4 expression.  
mRNA data about FAS and Leptin was only retrieved during one trial.  A second 
attempt to retrieve this data could not be made in the experimental time frame.  
Because this data was not reproduced (confirmed) it was omitted.  No 
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conclusion can be made from this information as to if PRMT4 is needed for 
adipose differentiation.  
 
Suggestions to Improve Viral Infection of MEF 13 cells 
Incomplete mRNA and lipid data in the PRMT4 experiment was caused by a 
lack of cells that were infected with the PPAR-gamma viruses.  Specifically, 
MEF13 cells infected by either the MOCK or PPAR-gamma viruses were difficult 
to obtain from the few cells that survived viral selection.  Few MEF13 cells were 
successfully infected by the viruses and given Puromycin resistance.  As a result, 
when puromycin was added to the MEF13 plates to select for viral infected cells , 
most of the MEF13 cells died.  To improve the efficiency of viral infection in the 
future, MEF13 cells should be infected with virus at 75% confluence (instead of 
50%).  In this case, the cells are still dividing and would incorporate the viral 
genes into their DNA.  And, there would be more cells infected on the plate, 
increasing the numbers of surviving cells.  This would enable the surviving cells to 
more quickly repopulate the plate.  
 
 In addition to infecting the MEF 13 plates at 75% confluence, the PPAR-gamma  
and MOCK viruses should be harvested from the supernatant of the BOSC cells 
the moment before infection.  This way, the virus does not have to be frozen and 
preserved.  Freezing a virus can reduce the number of virus particles that can 
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successfully infect cells.  In fact, using this technique near the end of the 
experiment did increase the number of MEF 13 cells infected by the viruses.   
 
 Another way to improve the MEF 13 viral infection is to infect a substantial 
number of MEF 13 plates.  This way, cells that survive puromycin selection can be 
“pooled” together and can more quickly become confluent.   
 
Suggestions to address Innate Puromycin Resistance in C15 and MEF 20.3 cells 
One issue associated with this experiment was puromycin resistance.  Both the 
PPAR-gamma and mock viruses conferred puromycin resistance to cells so that 
they could be selected for.  However, two of the cell lines used, MEF 20.3 and 
C15, had innate puromycin resistance.  Because of this, there was no way to kill 
these cells that were not infected with the virus.    To address this issue, new cell 
lines that do not contain PURO resistance should be used.  This way, cells can be 
selected for after viral infection.  After selection, only the cells infected with the 
virus would survive.  Then, these cells would divide and fill the plate.  It should be 
noted, that this issue was addressed by adjusting data such that the expression 
of PPAR-gamma mRNA was equal for all cell-lines.  
 
Outlook 
  
 - 64 - 
While the PRMT5 experiment shows substantial data to suggest PRMT5 is needed 
for adipose differentiation, protein data would make the argument more 
convincing.  Data showing adipocyte protein marker production decreasing in 
PRMT5- cell lines would improve the argument for PRMT5 playing a role in 
adipose differentiation.  This is an important idea because mRNA expression 
levels do not always correspond to protein expression levels.  Protein expression 
data corresponding to mRNA expression data would provide strong evidence 
confirming the mRNA results. 
 
In addition, redoing the PRMT4 experiment with the inclusion of protein data 
would help make PRMT4’s role in adipose differentiation known.  Using the 
suggestions made in this project, achieving PRMT4 data on adipose mRNA 
expression and lipid formation is likely. 
 
Knowing the role of PRMT4 and PRMT5 in adipose differentiation would help 
clarify the role of PRMTs in the differentiation process.  Recent findings about the 
role of PRMTs in muscle differentiation led to the creation of this project.  A new 
finding that PRMTs are involved in adipose differentiation could stimulate more 
research about PRMTs and their role in differentiation of other cell types, such as 
neurons, bone cells, or blood cells.   
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